Both in R&D — Physical & Biological Sciences
Charles River Laboratories International vs IB Acquisition
Over the past year CRL returned +99.7% and IBAC returned +4.1%; their daily moves had a correlation of -0.02.
CRL +99.7% IBAC +4.1%Growth of $1, one year, split-adjusted
| Metric | CRL | IBAC |
|---|---|---|
| Price | $359.41 | $10.86 |
| Market cap | $17.16B | $54.4M |
| Today | −4.44% | 0.00% |
| 1 month | +25.3% | −0.5% |
| 6 months | +116.8% | +0.4% |
| Year to date | +80.2% | +3.4% |
| 1 year | +99.5% | — |
| Revenue growth (YoY) | −2.7% | — |
| Gross margin | 36.2% | — |
| Net margin | −0.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.3× | — |
| Net cash | -$2.43B | — |
| Dividend yield | — | — |
| Volatility (60d) | 39.2% | 20.1% |
| Short % of float | 6.0% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).